Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Misfolded alpha-synuclein (AS) and other neurodegenerative disorder proteins display prion-like transmission of protein aggregation. Factors responsible for the initiation of AS aggregation are unknown. To evaluate the role of amyloid proteins made by the microbiota we exposed aged rats and transgenic C . elegans to E . coli producing the extracellular bacterial amyloid protein curli. Rats exposed to curli-producing bacteria displayed increased neuronal AS deposition in both gut and brain and enhanced microgliosis and astrogliosis compared to rats exposed to either mutant bacteria unable to synthesize curli, or to vehicle alone. Animals exposed to curli producing bacteria also had more expression of TLR2, IL-6 and TNF in the brain than the other two groups. There were no differences among the rat groups in survival, body weight, inflammation in the mouth, retina, kidneys or gut epithelia, and circulating cytokine levels. AS-expressing C . elegans fed on curli-producing bacteria also had enhanced AS aggregation. These results suggest that bacterial amyloid functions as a trigger to initiate AS aggregation through cross-seeding and also primes responses of the innate immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A study of Fischer-344 wild-type rats, which spontaneously develop asymptomatic α-synuclein pathology in the enteric nervous system in old age, showed that they will begin to develop pathological α-synuclein deposits in the brain and parkinsonian motor symptoms when their microbiome is disturbed through introduction of Escherichia coli [86, 87].”
From The gut–brain axis in early Parkinson’s disease: from prodrome to prevention (2025) · cites this paper as [86]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Exposure to curli-producing bacteria increases the deposition and accumulation of a-synuclein in intestinal ganglion cells (myenteric plexus and submucosa) and the brain, respectively, as well as increasing the inflammatory response in the brain.131”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [131]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 2×
“Our findings of microgliosis, astrogliosis and enhanced expression of IL-6, TLR2 and TNF in the brain following curli exposure suggest the occurrence of an enhanced local sterile inflammatory response to AS in the brain.”
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164 · cited 1×
“The precise role of protein aggregation and inflammation in neurodegeneration remains unclear 33 .”
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Regression Models for Ordinal Data
McCullagh, P. (1980) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1980.tb01109.x · Cited by 4,453
The Cellular Phase of Alzheimer’s Disease
De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
Self-citationα-Synuclein strains cause distinct synucleinopathies after local and systemic administration
Peelaerts, W., Bousset, L., Van der Perren, A., Moskalyuk, A., Pulizzi, R., Giugliano, M., Van den Haute, C., Melki, R., & Baekelandt, V. (2015) · Nature · doi:10.1038/nature14547 · Cited by 1,130
Peripheral education of the immune system by colonic commensal microbiota
Lathrop, S. K., Bloom, S. M., Rao, S. M., Nutsch, K., Lio, C.-W., Santacruz, N., Peterson, D. A., Stappenbeck, T. S., & Hsieh, C.-S. (2011) · Nature · doi:10.1038/nature10434 · Cited by 1,034 · cited 2×
“The following antibodies were used: α -synuclein (Syn-1; BD Bioscience, San Diego, CA); TNF α , glial fibrillary acidic protein (GFAP) (GA5), TH, and NeuN (Millipore, County Cork, Ireland); β -actin (Sigma-Aldrich, St Louis, MO); NF-κ B p65 and phospho-NF-κ B p65 (Cell Signaling, Beverly, MA); IL-1 β and IL6 (Abcam, C…”
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., Mc Coy, K. D., Frisoni, G., Neher, J. J., Fåk, F., Jucker, M., Lasser, T., et al. (2017) · Scientific Reports · doi:10.1038/srep41802 · Cited by 901
Neutrophils promote Alzheimer's disease–like pathology and cognitive decline via LFA-1 integrin
Zenaro, E., Pietronigro, E., Bianca, V. D., Piacentino, G., Marongiu, L., Budui, S., Turano, E., Rossi, B., Angiari, S., Dusi, S., et al. (2015) · Nature Medicine · doi:10.1038/nm.3913 · Cited by 865 · cited 1×
“It has recently been reported that circulating neutrophils contribute to AS pathology in transgenic mice 15 .”
Cited by
Items 201–300 of 463
Gut microbiota, pathogenic proteins and neurodegenerative diseases
Wei, W., Wang, S., Xu, C., Zhou, X., Lian, X., He, L., & Li, K. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.959856 · Cited by 33
“Bacterial amyloid protein has been identified as pathogen-associated molecular pattern (PAMP), and its communication messengers include TLR1/2, CD14, NF-κB and iNOS (Chen et al., 2016).”
BackgroundMoné, Y., Earl, J. P., Król, J. E., Ahmed, A., Sen, B., Ehrlich, G. D., & Lapides, J. R. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1123228 · Cited by 30
Suman, P. R., Souza, L. S., Kincheski, G. C., Melo, H. M., Machado, M. N., Carvalho, G. M. C., Felice, F. G. D., Zin, W. A., & Ferreira, S. T. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02662-0 · Cited by 30
“Exposure to microbial amyloids in the gastrointestinal tract can accelerate alpha-synuclein aggregation in the gut and brain, and lead to enhanced microgliosis and astrogliosis, suggesting that bacterial amyloid may function as a trigger to initiate brain inflammation and alpha-synuclein aggregation in synucleinopathi…”
BackgroundAcute inflammation down‐regulates alpha‐synuclein expression in enteric neurons
Prigent, A., Gonzales, J. A., Durand, T., Berre‐Scoul, C. L., Rolli‐Derkinderen, M., Neunlist, M., & Derkinderen, P. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14656 · Cited by 32
In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
Fouka, M., Mavroeidi, P., Tsaka, G., & Xilouri, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.559791 · Cited by 29
“Even though initially phosphorylation of α-synuclein was considered to act prophylactically to protein aggregation, it is now widely accepted that it precedes fibril formation (Shahpasandzadeh et al., 2014; Tenreiro et al., 2014; Oueslati, 2016).”
BackgroundInfluentialProgression of Nonmotor Symptoms in Parkinson’s Disease by Sex and Motor Laterality
Kurlawala, Z., Shadowen, P. H., McMillan, J. D., Beverly, L. J., & Friedland, R. P. (2021) · Parkinson s Disease · doi:10.1155/2021/8898887 · Cited by 32
Self-citationLipták, R., Gromová, B., & Gardlík, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.665520 · Cited by 30
Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives
Vassilakopoulou, V., Karachaliou, C., Evangelou, A., Zikos, C. C., & Livaniou, E. (2021) · Vaccines · doi:10.3390/vaccines9111278 · Cited by 30
Mhatre‐Winters, I., Eid, A., Han, Y., Tieu, K., & Richardson, J. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179829 · Cited by 26
Manipulation of the diet–microbiota–brain axis in Alzheimer’s disease
Lee, D. D., Lee, V. M. ‐., & Hur, S. K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1042865 · Cited by 29
“Other than contributions to the autoimmune process, it has been hypothesized that bacterial amyloids may indirectly induce the aggregation of human amyloidogenic proteins (Friedland, 2015; Chen et al., 2016; Miraglia and Colla, 2019).”
BackgroundTowards early detection of neurodegenerative diseases: A gut feeling
Makdissi, S., Parsons, B., & Cara, F. D. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1087091 · Cited by 30
“This hypothesis was confirmed from preliminary data in Rattus norvegicus fed with bacteria that produce the prion-like protein, curli, which resulted in α-Synuclein deposition accumulation in the gut and brain (Chen et al., 2016).”
BackgroundResultInfluentialRiegelman, E., Xue, K. S., Wang, J.-S., & Tang, L. (2024) · Nutrients · doi:10.3390/nu16132041 · Cited by 36
“…an increase in α -synuclein fibril reactivity and accumulation of insoluble α -synuclein in the substantia nigra portion of the midbrain compared to controls, indicating that exposure to microbial amyloids in the GI may accelerate α -synuclein aggregation in the gut and brain [129,130].”
BackgroundChan, D. G., Ventura, K., Villeneuve, A., Du Bois, P., & Holahan, M. R. (2022) · Journal of Parkinson's Disease · doi:10.3233/jpd-223461 · Cited by 24
“coli genome encodes an amyloidogenic protein, CsgA that is the main component of biofilm that encompasses several bacteria [61].”
BackgroundMicrobial amyloids in neurodegenerative amyloid diseases
Sampson, T. R. (2023) · FEBS Journal · doi:10.1111/febs.17023 · Cited by 28
Cytotoxic Curli Intermediates Form during Salmonella Biofilm Development
Nicastro, L. K., Tursi, S. A., Le, L. S., Miller, A. L., Efimov, A., Buttaro, B. A., Tam, V. C., & Tükel, Ç. (2019) · Journal of Bacteriology · doi:10.1128/jb.00095-19 · Cited by 26
“Intriguingly, recent studies suggested a connection between bacterial amyloid curli and two complex human diseases, systemic lupus erythematosus and Parkinson’s disease (13, 27).”
BackgroundEmergence of Caenorhabditis elegans as a Model Organism for Dissecting the Gut–Brain Axis
de Ora, L. O., & Bess, E. N. (2021) · mSystems · doi:10.1128/msystems.00755-21 · Cited by 25
“elegans has been shown to cause a similar effect in the mammalian gut, demonstrating the translational potential of this nematode to mammalian biological processes (23).”
BackgroundVertebrate food products as a potential source of prion-like α-synuclein
Killinger, B. A., & Labrie, V. (2017) · npj Parkinson s Disease · doi:10.1038/s41531-017-0035-z · Cited by 25
“Several recent studies have, in part, supported this “gut to brain” hypothesis of PD.(71,72) α-Synuclein is endogenously expressed in enteric neurons throughout the gastrointestinal (GI) system and PD-like α-synuclein pathology has been documented in intestinal tissues of PD patients(68,73,74) and prodromal-PD patient…”
BackgroundResultModulation of the Microbiome in Parkinson's Disease: Diet, Drug, Stool Transplant, and Beyond
Brown, E. G., & Goldman, S. M. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00942-2 · Cited by 28
“cific types of amyloid protein can induce alpha-synuclein aggregation and inflammation in the gut and brain [67].”
BackgroundEffects of gut microbiota and probiotics on Alzheimer’s disease
Guo, L., Xu, J., Du, Y., Wu, W., Nie, W., Zhang, D., Luo, Y., Lu, H., Lei, M., Xiao, S., et al. (2021) · Translational Neuroscience · doi:10.1515/tnsci-2020-0203 · Cited by 29
“Bacterial amyloid proteins are also found to promote misfolding and aggregation of neuronal Aβ peptides through cross-seeding [30,34,35].”
BackgroundGut Microbiota as a Hidden Player in the Pathogenesis of Alzheimer’s Disease
Choi, H., Lee, D., & Mook‐Jung, I. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215235 · Cited by 24
“-syn deposition in both gut and brain, along with enhanced inflammation indicated by microgliosis and astrogliosis [217].”
Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease
Pavan, S., Prabhu, A., Gorthi, S. P., Das, B., Mutreja, A., Shetty, V., Ramamurthy, T., & Ballal, M. (2022) · Folia Microbiologica · doi:10.1007/s12223-022-00977-2 · Cited by 25
“Researchers have also observed that exposure to bacteria-producing amyloid protein curli can induce α-syn accumulation in the gut and brain of mice (Chen et al. 2016).”
BackgroundWu, Y., Niu, X., Li, P., Tong, T., Wang, Q., Zhang, M., Li, Y., Liu, J., & Li, Z. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03466-3 · Cited by 29
Patil, R. S., & Tupe, R. S. (2023) · Medicinal Research Reviews · doi:10.1002/med.21987 · Cited by 26
Kulkarni, R., Kumari, S., Dhapola, R., Sharma, P., Singh, S. K., Medhi, B., & HariKrishnaReddy, D. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04545-2 · Cited by 29
“It was found that when an animal’s brain is revealed to curli-producing bacteria, the expression of TNF-α, IL-6, and TLR 2 increases [79].”
Wang, C., & Zheng, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.875349 · Cited by 24
Gut Microbiota as a Modifier of Huntington’s Disease Pathogenesis
Khoshnan, A. (2024) · Journal of Huntington s Disease · doi:10.3233/jhd-240012 · Cited by 24
“Functional bacterial amyloids Curli produced by members of Enterobacteriaceae like E. coli , Salmonella, and Shigella, seed the aggregation of a-synuclein protein and accelerate PD pathology in several animal models like C. elegans, mice, and rats [44, 60, 61].”
BackgroundPark, S. J., Kim, K. W., & Lee, E. J. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00994 · Cited by 28
Alpha-synuclein: prion or prion-like?
Leak, R. K., Frosch, M. P., Beach, T. G., & Halliday, G. M. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02057-1 · Cited by 30
Kumar, D., Bishnoi, M., Kondepudi, K. K., & Sharma, S. S. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10433-x · Cited by 31
“Similarly, another study also found that exposure to the bacteria Escherichia coli in a rat initiates α-synuclein aggregation in the gut as well as CNS [52].”
Haikal, C., Ortigosa-Pascual, L., Najarzadeh, Z., Bernfur, K., Svanbergsson, A., Otzen, D. E., Linse, S. S., & Li, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111594 · Cited by 22
Zhang, W., Dong, X., & Huang, R. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106787 · Cited by 24
The Role of the Gut Microbiota and Microbial Metabolites in the Pathogenesis of Alzheimer’s Disease
Wang, Y. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220417005115 · Cited by 21
The Gut Microbiome and Alzheimer’s Disease: A Growing Relationship
Zerdan, M. B., Hebbo, E., Hijazi, A., Gemayel, M. E., Nasr, J., Nasr, D., Yaghi, M., Bouferraa, Y., & Nagarajan, A. (2022) · Current Alzheimer Research · doi:10.2174/1567205020666221227090125 · Cited by 24
Dysbiosis of the Beneficial Gut Bacteria in Patients with Parkinson’s Disease from India
Pavan, S., Gorthi, S. P., Prabhu, A., Das, B., Mutreja, A., Vasudevan, K., Shetty, V., Ramamurthy, T., & Ballal, M. (2023) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_460_23 · Cited by 22
Frézal, L., Saglio, M., Zhang, G., Noble, L. M., Richaud, A., & Félix, M. (2023) · EMBO Reports · doi:10.15252/embr.202358116 · Cited by 19
Maguire, G. (2017) · World Journal of Stem Cells · doi:10.4252/wjsc.v9.i11.187 · Cited by 24
Hill, A. E., Wade‐Martins, R., & Burnet, P. W. J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.708587 · Cited by 20
Pasko, V. I., Churkina, A. S., Shakhov, A. S., Kotlobay, A. A., & Alieva, I. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010604 · Cited by 23
Zhao, R., Mu, B., Wang, D., XinHuang, Ma, Q., & Lu, M. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04584-9 · Cited by 29
“…study noted that rats exposed to curli-producing bacteria had increased neuronal AS (misfolded α-synuclein) in the gut and brain and enhanced IL-6, TLR2, and TNF expression in microglia and astrocytes compared to rats exposed to bacteria that were unable to synthesize curly amyloid fibrils [98].”
Ibacache‐Quiroga, C., González-Pizarro, K., Charifeh, M., Canales, C., Díaz, R., Schmachtenberg, O., & Dinamarca, M. A. (2022) · Foods · doi:10.3390/foods11070900 · Cited by 21
Structural Mimicry in Microbial and Antimicrobial Amyloids
Golan, N., Engelberg, Y., & Landau, M. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-032620-105157 · Cited by 20
The gastrointestinal tract and Parkinson’s disease
Higinbotham, A. S., & Kilbane, C. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1158986 · Cited by 24
More than just a number: the gut microbiota and brain function across the extremes of life
Nuzum, N. D., Deady, C., Kittel‐Schneider, S., Cryan, J. F., O’Mahony, S. M., & Clarke, G. A. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2418988 · Cited by 25
Formation of Heterotypic Amyloids: α‐Synuclein in Co‐Aggregation
Bhasne, K., & Mukhopadhyay, S. (2018) · PROTEOMICS · doi:10.1002/pmic.201800059 · Cited by 18
Bacterial Amyloids: Biogenesis and Biomaterials
Christensen, L. F. B., Schafer, N. P., Wolf-Perez, A., Madsen, D. J., & Otzen, D. E. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9791-2_4 · Cited by 19
The Role of The Gut Microbiome in Parkinson’s Disease
Gallop, A., Weagley, J. S., Paracha, S.-U.-R., & Grossberg, G. T. (2021) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887211018268 · Cited by 20
Modulation of Innate Immunity by Amyloidogenic Peptides
Westwell-Roper, C. Y., & Verchere, C. B. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.06.005 · Cited by 18
Grathwohl, S., Quansah, E., Maroof, N., Steiner, J. A., Spycher, L., Benmansour, F., Duran-Pacheco, G., Siebourg-Polster, J., Oroszlan-Szovik, K., Remy, H., et al. (2020) · doi:10.21203/rs.3.rs-100199/v1 · Cited by 17
“In this context, it is also notable that people with Crohn’s disease present with increased enteric αSyn expression [55] and even more striking that IBD patients on anti-TNF therapy have a reduced risk of developing PD compared to IBD patients not given this treatment [35].”
BackgroundInfluentialBeg, A. Z., Farhat, N., & Khan, A. U. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104982 · Cited by 19
Wittung-Stafshede, P. E. (2021) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2021.07.009 · Cited by 16
Chen, W., Bi, Z., Zhu, Q., Gao, H., Fan, Y., Zhang, C., Liu, X., & Ye, M. (2021) · PubMed · Cited by 24
Raj, K., Singh, S., Chib, S., & Mallan, S. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666221003112300 · Cited by 17
Xiromerisiou, G., Marogianni, C., Androutsopoulou, A., Ntavaroukas, P., Mysiris, D. S., & Papoutsopoulou, S. (2023) · Biology · doi:10.3390/biology12010093 · Cited by 22
“The first study states that gut lumen (Escherichia coli) releases the extracellular amyloid protein Curli [27], which in rats could induce the disposition of a-synuclein in both the gut and the brain [28].”
BackgroundCAVALCANTI, S. A. D. Q., de Almeida, L. A., & Gasparotto, J. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578171 · Cited by 19
Verstraelen, P., Remoortel, S. V., Loose, N. D., Verboven, R., Barriga, G. G.-D., Christmann, A., Gries, M., Bessho, S., Li, J., Guerra, C. E., et al. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.03.013 · Cited by 17
Cao, H., Tian, Q., Chu, L., Wu, L., Gao, H., & Gao, Q. (2024) · Food & Function · doi:10.1039/d4fo01878h · Cited by 17
Infectious Agents as Potential Drivers of α‐Synucleinopathies
Linard, M., Ravier, A., Mougué, L., Grgurina, I., Boutillier, A., Foubert‐Samier, A., Blanc, F., & Helmer, C. (2022) · Movement Disorders · doi:10.1002/mds.28925 · Cited by 19
“Finally, αS appears to modulate innate and adaptive immune responses,(36) including the recruitment and/or activation of the complement system, microglial cells, monocytes, and T cells.(25,26,32,33,37-39) For example, a study using duodenal biopsies from 42 children presenting gastroduodenal inflammation showed that t…”
BackgroundBessho, S., Grando, K. C. M., Kyrylchuk, K., Miller, A. L., Klein–Szanto, A. J., Zhu, W., Gallucci, S., Tam, V. C., & Tükel, Ç. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2221813 · Cited by 16
Gut-to-brain spreading of pathology in synucleinopathies: A focus on molecular signalling mediators
Schmitt, V., Masanetz, R. K., Weidenfeller, M., Ebbinghaus, L. S., Süß, P., Rosshart, S. P., von Hörsten, S., Zunke, F., Winkler, J., & Xiang, W. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114574 · Cited by 17
Walker, A. C., Bhargava, R., Bucher, M. J., Argote, Y. M., Brust, A. S., & Czyż, D. M. (2024) · iScience · doi:10.1016/j.isci.2024.110828 · Cited by 15
Interactions between pathological and functional amyloid: A match made in Heaven or Hell?
Otzen, D. E., Peña‐Díaz, S., Widmann, J., Daugberg, A. O. H., Zhang, Z., Jiang, Y., Mittal, C., Dueholm, M. S., Louros, N. N., Wang, H., et al. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101351 · Cited by 16
Mercado, G., Käufer, C., Richter, F., & Peelaerts, W. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-240195 · Cited by 20
“230 Aside from gut bacteria, viral gut pathogens have also been associated with synucleinopathy.”
BackgroundHow leaky is the gut in Parkinson’s disease?
Derkinderen, P., Cossais, F., Kulcsárová, K., Škorvánek, M., Montaigne, L. S., Coron, E., Leclair‐Visonneau, L., Cerri, S., Pellegrini, C., & Rolli‐Derkinderen, M. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105796 · Cited by 23
The Evolution of Functional Amyloids and Their Impact on Host–Microbe Interactions
Kolli, D., Rout, S. K., Riek, R., & Chapman, M. R. (2025) · Advanced Science · doi:10.1002/advs.202510109 · Cited by 17
Barbu, A. C., Stoleru, S., Zugravu, A., Poenaru, E., Dragomir, A.-F., Costescu, M., Aurelian, S. M., Shhab, Y., Stoleru, C. M., Coman, O. A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010271 · Cited by 22
“Neural signaling is the most direct route; dopamine modulates ENS activity and vagal afferents, and vagotomy abolishes microbiota-driven effects on central dopaminergic circuits in animal models [81–83].”
Radisavljevic, N., Cirstea, M. S., Bauer, K. C., Lo, C., Metcalfe‐Roach, A., Bozorgmehr, T., Bar‐Yoseph, H., & Finlay, B. B. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223165 · Cited by 17
Bacteria-Derived Protein Aggregates Contribute to the Disruption of Host Proteostasis
Walker, A. C., Bhargava, R., Dove, A. S., Brust, A. S., Owji, A. A., & Czyż, D. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094807 · Cited by 18
“Additional studies have demonstrated that Escherichia coli curli fibers increase α-synuclein aggregation in rodents and Caenorhabditis elegans [11,26].”
ResultConsonni, A., Miglietti, M., Luca, C. M. G. D., Cazzaniga, F. A., Ciullini, A., Dellarole, I. L., Bufano, G., Fonzo, A. D., Giaccone, G., Baggi, F., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12111579 · Cited by 15
AmyloComp: A Bioinformatic Tool for Prediction of Amyloid Co-aggregation
Bondarev, S. A., Uspenskaya, M. V., Leclercq, J. Y., Falgarone, T., Zhouravleva, G. A., & Kajava, A. V. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168437 · Cited by 13
Development of in vitro model of exosome transport in microfluidic gut-brain axis-on-a-chip
Seo, G. M., Lee, H., Kang, Y. J., Kim, D., & Sung, J. H. (2024) · Lab on a Chip · doi:10.1039/d4lc00490f · Cited by 15
Manole, E., Dumitrescu, L., Niculite, C. M., Popescu, B. O., & Ceafalan, L. C. (2021) · Biocell · doi:10.32604/biocell.2021.013452 · Cited by 15
“coli enhanced the aggregation of human alpha-synuclein in Fisher 344 rat brains and transgenic Caenorhabditis elegans muscle (Chen et al., 2016).”
BackgroundInfluentialIs the Gut Microbiota a Neglected Aspect of Gut and Brain Disorders?
Balan, Y., Gaur, A., Sakthivadivel, V., Kamble, B. D., & Sundaramurthy, R. (2021) · Cureus · doi:10.7759/cureus.19740 · Cited by 18
“Patients with Parkinson’s disease often complain of GI symptoms, such as constipation and inflammatory bowel disease (IBD)-like symptoms, which led scientists to explore the GI system in Parkinson’s disease [26,27].”
BackgroundMitochondria-Microbiota Interaction in Neurodegeneration
Krämer, P. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.776936 · Cited by 14
Luyckx, T., Grootaert, C., Monge‐Morera, M., Delcour, J. A., Rousseau, F., Schymkowitz, J. W. H., & Camp, J. V. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202101032 · Cited by 14
Ayan, E. B., DeMirci, H., Serdar, M. A., Palermo, F., & Baykal, A. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612819 · Cited by 16
Antibodies and α-synuclein: What to target against Parkinson's Disease?
Otzen, D. E. (2023) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2023.140943 · Cited by 13
Andriolo, I. R. L., Longo, B. C., de Melo, D. M., de Souza, M. M., Prediger, R. D., & da Silva, L. M. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273289138240306050532 · Cited by 20
Yao, L., Yang, Y., Yang, X., & Rezaei, M. J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04151-2 · Cited by 16
“This supports the involvement of microbial functional amyloid proteins in the pathophysiology related to PD [107].”
Amyloids and Amyloid-like Protein Aggregates in Foods: Challenges and New Perspectives
Malik, S., & Yadav, J. K. (2023) · Current Protein and Peptide Science · doi:10.2174/1389203724666230104163924 · Cited by 12
Mutant and curli-producing E. coli enhance the disease phenotype in a hSOD1-G93A mouse model of ALS
Kurlawala, Z., McMillan, J. D., Singhal, R. A., Morehouse, J. R., Burke, D. A., Sears, S. M., Duregon, E., Beverly, L. J., Siskind, L. J., & Friedland, R. P. (2023) · Scientific Reports · doi:10.1038/s41598-023-32594-5 · Cited by 12
Self-citationThe major histocompatibility complex participates in Parkinson’s disease
Gu, R., Pan, J., Awan, M. U. N., Sun, X., Fang, Y., Bai, L., & Bai, J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107168 · Cited by 15
Ngah, W. Z. W., Ahmad, H. F., Ankasha, S. J., Makpol, S., & Tooyama, I. (2024) · Antioxidants · doi:10.3390/antiox13121504 · Cited by 13
Lewy body diseases and the gut
Sampson, T. R., Tansey, M. G., West, A. B., & Liddle, R. A. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00804-5 · Cited by 14
Gut dysbiosis in Down syndrome: A potentially unexplored culprit for early Alzheimer's disease
Rosas, H. D., Morgan, X. C., Tao, Y., Lai, F., & Mercaldo, N. D. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70330 · Cited by 13
Recent advances in pre-clinical diagnosis of Alzheimer’s disease
Zhou, J., Benoit, M., & Sharoar, M. G. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00733-4 · Cited by 15
“Heliobacter pylori infection was correlatedwith AD diagnosis and reduced cognition in patients (Chen et al. 2016).”
BackgroundChristensen, L. F. B., Alijanvand, S. H., Burdukiewicz, M., Herbst, F., Kjeldal, H., Dueholm, M. S., & Otzen, D. E. (2021) · Protein Science · doi:10.1002/pro.4137 · Cited by 11
“coli strain.(19) Similar experiments have been performed in an transgenic (Tg) mouse model overexpressing αSN and again showed that exposure to curli correlated with increased αSN pathology in the gut and brain together with GI and motor deficits.”
BackgroundImpact of environmental toxicants exposure on gut-brain axis in Parkinson disease
Olubodun-Obadun, T. G., Ishola, I. O., & Adeyemi, O. O. (2022) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2021-0144 · Cited by 13
Microbiome Impact on Amyloidogenesis
Curto, J. S., Lopez, A. S., Sanchez, M. C., Tic, I., Fernández, M. R., & de Groot, N. S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.926702 · Cited by 13
Beg, A. Z., Rashid, F., Talat, A., Haseen, M. A., Raza, N., Akhtar, K., Dueholm, M. S., & Khan, A. U. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.03071-22 · Cited by 12
Experimental colitis drives enteric alpha-synuclein accumulation and Parkinson-like brain pathologyPreprint
Grathwohl, S. A., Quansah, E., Maroof, N., Steiner, J. A., Spycher, L., Benmansour, F., Durán-Pacheco, G., Siebourg‐Polster, J., Oroszlan‐Szovik, K., Remy, H., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/505164 · Cited by 14
Overview of the Gut Microbiome
Blackmer‐Raynolds, L., & Sampson, T. R. (2023) · Seminars in Neurology · doi:10.1055/s-0043-1771463 · Cited by 12
Hsiao, Y.-K., Lee, B., & Wu, S. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1305617 · Cited by 15
Jain, N. (2024) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2024.141018 · Cited by 12
Pesticides and the Gut Microbiota: Implications for Parkinson’s Disease
Ghosh, N., Sinha, K., & Sil, P. C. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.4c00057 · Cited by 11
The Intricate Interplay: Microbial Metabolites and the Gut‐Liver‐Brain Axis in Parkinson's Disease
Kishanchand, D. K., A., A. K. K., Chandrababu, K., Philips, C. A., Sivan, U., & Chakrapani, P. S. B. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70016 · Cited by 15
“(Chen et al. 2016; Sampson et al. 2020).”
Intriguing Role of Gut-Brain Axis on Cognition with an Emphasis on Interaction with Papez Circuit
Xavier, J., Anu, M., Fathima, A. S., Ravichandiran, V., & Kumar, N. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220614124145 · Cited by 11
Gut-oriented disease modifying therapy for Parkinson's disease
Lin, C., Lai, H., & Wu, M. (2022) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2022.09.010 · Cited by 12
PACT - Prediction of amyloid cross-interaction by threading
Wojciechowski, J. W., Szczurek, W., Szulc, N., Szefczyk, M., & Kotulska, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-48886-9 · Cited by 12
“More recent studies have shown that in some cases presence of amyloid aggregates can affect the aggregation rate of other proteins [24].”
BackgroundGut microbiota: a potential therapeutic target for Parkinson’s disease
Baizabal‐Carvallo, J. F. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.290896 · Cited by 12
“Indeed, repeated administration of curli-producing bacteria to Caenorhabditis elegans and rats has induced neuronal deposition of α-synuclein in their gut and CNS promoting local inflammation (Chen et al., 2016).”
BackgroundBiofilm-Associated Amyloid Proteins Linked with the Progression of Neurodegenerative Diseases
Singh, A. A., Khan, F., & Song, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062695 · Cited by 12
“Curli-exposed rats showed considerably greater α -synuclein deposition in the gut, with an odds ratio of 2.5 (95% CI 4.4–239), suggesting a dramatically increased risk of higher gut scores than unexposed rats [90].”
Influential
Metadata
- Authors
- Chen, S. G., Stribinskis, V., Rane, M. J., Demuth, D. R., Gozal, E., Roberts, A. M., Jagadapillai, R., Liu, R., Choe, K., Shivakumar, B., Son, F., Jin, S., Kerber, R., Adame, A., Masliah, E., & Friedland, R. P.
- Affiliations
- Case Western Reserve University (US)
- University of Louisville (US)
- University of California San Diego (US)
- Corresponding author
- Friedland, Robert P.
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-10-06
- Volume
- 6
- Issue
- 1
- Pages
- 34477-34477
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5052651
- OpenAlex
- W2528438579
- Semantic Scholar
- 8941d2a0855c5ed0f4d041db3a0b4426e019b757
- Cited by
- 463
- References
- 53
- Citations by year
- 2026: 27 · 2025: 44 · 2024: 62 · 2023: 57 · 2022: 72 · 2021: 74 · 2020: 45 · 2019: 45 · 2018: 17 · 2017: 19 · 2016: 1
- FWCI
- 20.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Michael J. Fox Foundation for Parkinson's Research
- University of Louisville
- National Institute on Aging (P50AG005131)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- alpha-synuclein aggregation, curli, bacterial amyloids, prion-like transmission, cross-seeding, gut microbiota, neuroinflammation, microglial activation, astrocyte activation, innate immune response, TLR2, interleukin-6, TNF-α, aged rats, Caenorhabditis elegans, Escherichia coli, neurodegenerative diseases
- MeSH terms
- Amyloid, Animals, Bacterial Proteins, Escherichia coli, Rats, Inbred F344, Caenorhabditis elegans, Escherichia coli Proteins, Rats, alpha-Synuclein, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.